mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0039 |
0.9 |
mRNA |
ML050 |
CTRPv2 |
pan-cancer |
AAC |
0.0041 |
0.9 |
mRNA |
VER-155008 |
CTRPv2 |
pan-cancer |
AAC |
-0.0039 |
0.9 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0039 |
0.9 |
mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
0.0032 |
0.9 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
-0.0032 |
0.9 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.0048 |
0.9 |
mRNA |
BRD-K14844214 |
CTRPv2 |
pan-cancer |
AAC |
-0.004 |
0.9 |
mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
0.0036 |
0.9 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.003 |
0.9 |